• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Hemagglutinin-pseudotyped GFP-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.

Giuseppe

Emeritus
J Virol. 2009 Nov 25. [Epub ahead of print]

Hemagglutinin-pseudotyped GFP-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.

Mart?nez-Sobrido L, Cadagan R, Steel J, Basler CF, Palese P, Moran TM, Garc?a-Sastre A. - Departments of Microbiology, and Medicine, and Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.

Influenza virus is a highly contagious virus that causes yearly epidemics and occasional pandemics of great consequence. Influenza virus-neutralizing antibodies (NAbs) are promising prophylactic and therapeutic reagents. Detection of NAbs in serum samples is critical to evaluate the prevalence and spread of new virus strains. Here we describe the development of a simple, sensitive, specific and safe screening assay for the rapid detection of NAbs against highly pathogenic influenza viruses under BSL-2 conditions. This assay is based on the use of influenza viruses in which the hemagglutinin (HA) gene is replaced by one expressing GFP. These GFP-expressing influenza viruses replicate to high titers in HA-expressing cell lines, but in non-HA expressing cells their replication is restricted to a single cycle.

PMID: 19939917 [PubMed - as supplied by publisher]
-
------
 
Back
Top Bottom